Technical Program
All times are in Eastern Time (ET)
Note that this schedule is constantly evolving and subject to minor changes. Registered participants can log in to view additional speaker, session and abstract information.
Start Time | End Time | Thursday, October 01, 2020 |
9:00 AM | 10:00 AM | Poster Session |
10:00 AM | 10:05 AM | Welcome Remarks, Yvonne Chen, UCLA |
10:05 AM | 10:45 AM | Keynote Speaker: Chiara Bonini, Università San Raffaele |
Session 1: Clinical Applications Session Chair: Yvonne Chen, UCLA |
||
10:45 AM | 11:10 AM | Invited Speaker: CAR NK Cells: A Drive to the Future of Cell Therapy Katy Rezvani, MD Anderson Cancer Center |
11:10 AM | 11:35 AM | Invited Speaker: Preventing Antigen Escape with CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) T-Cells Sarah Larson, University of California, Los Angeles |
11:35 AM | 11:50 AM | Acoustic Imaging and Detonation of Cellular Therapies Avinoam Bar-Zion, Caltech |
11:50 AM | 11:55 AM | Stretch Break and Hallway Chats |
Session 2: CAR-T Cell Therapy Session Chair: Lior Nissim, Hebrew University of Jerusalem |
||
11:55 AM | 12:20 PM | Invited Speaker: An MHC-Independent Booster Vaccine for Chimeric Antigen Receptor T Cells Leyuan Ma, Koch Institute at MIT |
12:20 PM | 12:45 PM | Invited Speaker: Computational Design of Cars for Enhanced Control and Safety of T-Cell Therapies Bruno Correia, École Polytechnique Fédérale de Lausanne |
12:45 PM | 1:00 PM | Engineered T Cells Directed at Tumors with Defined Allelic Loss Breanna DiAndreth, a2biotherapeutics |
1:00 PM | 1:05 PM | Closing Remarks |
Start Time | End Time | Friday, October 02, 2020 |
9:00 AM | 10:00 AM | Poster Session |
10:00 AM | 10:05 AM | Opening Remarks |
Session 3: Oncolytic Viruses and Tumor Microenvironment Engineering Session Chair: Eliana Ruggiero, San Raffaele Scientific Institute, Milan |
||
10:05 AM | 10:30 AM | Invited Speaker: Dressing Viruses in Tumor’s Clothing: Cloning-Free Platforms to Trigger Tumor-Specific Immune Response Vincenzo Cerullo, University of Helsinki |
10:30 AM | 10:45 AM | Saul Priceman, City of Hope |
10:45 AM | 10:55 AM | Stretch Break and Hallway Chats |
Session 4: Synthetic & Systems Biology Session Chair: Lior Nissim, Hebrew University of Jerusalem |
||
10:55 AM | 11:20 AM | Invited Speaker: CRISPR Epigenetic Tools for Immunomodulation Samira Kiani, University of Pittsburgh |
11:20 AM | 11:45 AM | Invited Speaker: Engineering Enhanced Specificity and Selectivity of T Cell Therapeutics Sai T. Reddy, ETH Zurich |
11:45 AM | 12:00 PM | High-Efficiency System for Site-Specific Transgene Integration in Mammalian Cells Barbara Jusiak, Massachusetts Institute of Technology |
Session 5: Checkpoint Inhibition Session Chair: Antonella Sistigu, Università Cattolica del Sacro Cuore |
||
12:00 PM | 12:25 PM | Invited Speaker: Immune Checkpoint Inhibitors for Cancer Therapy – the Hidden Targets Michal Lotem, Hadassah Hebrew University Medical Center |
12:25 PM | 12:40 PM | LAG-3, but Not Tim-3, Disruption in TCR Gene Edited Human Memory Stem T Cells Enhance the Anti Tumor Activity Against Multiple Myeloma Beatrice Claudia Cianciotti, San Raffaele Scientific Institute |
12:40 PM | 1:10 PM | Summary of Day 2 Discussion & Closing Remarks |
Start Time | End Time | Saturday, October 03, 2020 |
9:00 AM | 9:05 AM | Welcome Remarks, Velia Siciliano, IIT |
9:05 AM | 9:45 AM | Keynote Speaker: Ron Weiss, Massachusetts Institute of Technology |
Session 6: Cancer Immunology Session Chair: Eliana Ruggiero, San Raffaele Scientific Institute, Milan |
||
9:45 AM | 10:10 AM | Invited Speaker: MR1T Cells Pave the Way for Novel Cancer Cell Therapies Gennaro De Libero, University of Basel |
10:10 AM | 10:35 AM | Invited Speaker: Delineation of the Immune Suppressive Network in Human Tumors – from Cells to Predictive Biomarkers Ilan Volovitz, Tel-Aviv Medical Center |
10:35 AM | 10:50 AM | The T Cell Exhaustion Signature Can Guide the Identification of Patient-Derived, Tumor-Reactive TCRs and Promote TCR Gene Editing for AML Francesco Manfredi, San Raffaele Scientific Institute |
10:50 AM | 10:55 AM | Stretch Break and Hallway Chats |
Session 7: CAR-T Cell Therapy (Part 2) Session Chair: Antonella Sistigu, Università Cattolica del Sacro Cuore |
||
10:55 AM | 11:20 AM | Invited Speaker: Solid Tumour: The New Challenge for the Immunotherapy Ignazio Caruana, IRCCS Bambino Gesù Children's Hospital |
11:20 AM | 11:45 AM | Thermal Control of Engineered T‐Cells Mohamad Abedi, Caltech |
11:45 AM | 11:50 AM | Closing Remarks |